-
Trial Begins of Precise Gene Editing for Heart Disease
A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease.
-
Diabetes Cell Therapy Biotech Acquired in $320M Deal
A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals.
-
Infographic – Q2 Venture Funds Decline Continues
Venture capital funds for North American technology start-ups continued their fall in the second quarter, with later-stage rounds showing the greatest drop.
-
AI Analytics Find New ALS Genetic Drug Targets
Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS.
-
Human Organoids Show Drug Activity in Lab Animals
A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats.
-
Precision Microbial Resistance Joint Venture Formed
Biotech, pharma, and diagnostics companies are forming a new business to design precision diagnostics and treatments for drug-resistant microbes.
-
CEPI Funds New Broad Coronavirus Vaccine
An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells.
-
Fourth of July 2022
Today is the U.S. national day, or Independence Day, celebrated on 4 July.
-
Infographic – Biotech Index Continues Decline in Q2
A new look at the Nasdaq Biotechnology Index shows investors’ chill in biotech stocks begun earlier in the year continued into the second quarter of 2022.
-
Smell Detection Tech Company Raises $4M in Seed Funds
A start-up biotechnology company creating a system that translates an animal’s sense of smell into electronic signals is raising $4 million in seed equity funds.